{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:29:42Z","timestamp":1786501782167,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["No. 2022A1515012355"],"award-info":[{"award-number":["No. 2022A1515012355"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82273365"],"award-info":[{"award-number":["No. 82273365"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00843-y","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:37:10Z","timestamp":1780483030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TRIM71 suppresses cervical cancer progression by inhibiting Nectin4-mediated Wnt\/\u03b2-catenin signaling"],"prefix":"10.1186","volume":"21","author":[{"given":"Tianyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diqiao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxi","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"3","key":"843_CR1","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1470-2045(19)30072-5","volume":"20","author":"M Brisson","year":"2019","unstructured":"Brisson M, Drolet M. Global elimination of cervical cancer as a public health problem. Lancet Oncol. 2019;20(3):319\u201321.","journal-title":"Lancet Oncol"},{"issue":"3","key":"843_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"17","key":"843_CR3","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1042\/CS20160786","volume":"131","author":"Graham","year":"2017","unstructured":"Graham SV. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. Clin Sci (London England: 1979). 2017;131(17):2201\u201321.","journal-title":"Clin Sci (London England: 1979)"},{"key":"843_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1476-4598-4-38","volume":"4","author":"A Due\u00f1as-Gonz\u00e1lez","year":"2005","unstructured":"Due\u00f1as-Gonz\u00e1lez A, Lizano M, Candelaria M, Cetina L, Arce C, Cervera E. Epigenetics of cervical cancer. An overview and therapeutic perspectives. Mol Cancer. 2005;4:38.","journal-title":"Mol Cancer"},{"key":"843_CR5","doi-asserted-by":"publisher","first-page":"104240","DOI":"10.1016\/j.critrevonc.2023.104240","volume":"194","author":"AS Kushwah","year":"2024","unstructured":"Kushwah AS, Masood S, Mishra R, Banerjee M. Genetic and epigenetic alterations in DNA repair genes and treatment outcome of chemoradiotherapy in cervical cancer. Crit Rev Oncol\/Hematol. 2024;194:104240.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"1","key":"843_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13027-025-00641-7","volume":"20","author":"Y Huang","year":"2025","unstructured":"Huang Y, Wang J, Yang W, Hou F, Feng X. Precision therapeutic targets for HPV-positive cancers: an overview and new insights. Infect Agent Cancer. 2025;20(1):17.","journal-title":"Infect Agent Cancer"},{"issue":"2","key":"843_CR7","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.4081\/oncol.2012.e17","volume":"6","author":"M Senba","year":"2012","unstructured":"Senba M, Mori N. Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection. Oncol Reviews. 2012;6(2):e17.","journal-title":"Oncol Reviews"},{"issue":"4","key":"843_CR8","doi-asserted-by":"publisher","first-page":"316","DOI":"10.2174\/0113892029293113240427065916","volume":"25","author":"MFF de Paula Filho","year":"2024","unstructured":"de Paula Filho MFF, Lopes Chris\u00f3stomo LL, Cansan\u00e7\u00e3o IF. HPV16 genomes: in silico analysis of e6 and e7 oncoproteins in 20 south american variants. Curr Genomics. 2024;25(4):316\u201321.","journal-title":"Curr Genomics"},{"key":"843_CR9","first-page":"320","volume":"20","author":"F Rasi Bonab","year":"2021","unstructured":"Rasi Bonab F, Baghbanzadeh A, Ghaseminia M, Bolandi N, Mokhtarzadeh A, Amini M, Dadashzadeh K, Hajiasgharzadeh K, Baradaran B, Bannazadeh Baghi H. Molecular pathways in the development of HPV-induced cervical cancer. Excli J. 2021;20:320\u201337.","journal-title":"Excli J"},{"key":"843_CR10","doi-asserted-by":"publisher","first-page":"e170223213775","DOI":"10.2174\/1874467216666230217151946","volume":"17","author":"Q Zeng","year":"2024","unstructured":"Zeng Q, Feng K, Yu Y, Lv Y. Hsa_circ_0000021 sponges mir-3940-3p\/KPNA2 expression to promote cervical cancer progression. Curr Mol Pharmacol. 2024;17:e170223213775.","journal-title":"Curr Mol Pharmacol"},{"key":"843_CR11","doi-asserted-by":"crossref","unstructured":"Rangaraj K, Vasudevan MT, Rangaraj S, Kumar R, Muthusami S, Alahmadi TA, Chinnathambi A, Arulselvan P, Chaiyasut C, Bharathi M. Synergistic antiproliferative effects of EGCG and myricetin on cervical cancer biomarkers in ME180 and SiHa cell lines. Curr Gene Ther. 2025:10\u20132174.","DOI":"10.2174\/0115665232363374250901071820"},{"issue":"8","key":"843_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2174\/0109298665365981250801110725","volume":"32","author":"M Gakhar","year":"2025","unstructured":"Gakhar M, Singh L, Routh S, Mukhopadhaya A, Singh DD. Evaluation of anti-cancer potential of abelmoschus esculentus (okra). Protein Pept Lett. 2025;32(8):575\u201383.","journal-title":"Protein Pept Lett"},{"issue":"1","key":"843_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, Zhou Z, Shu G, Yin G. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7(1):3.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"843_CR14","doi-asserted-by":"publisher","first-page":"a007880","DOI":"10.1101\/cshperspect.a007880","volume":"4","author":"BT MacDonald","year":"2012","unstructured":"MacDonald BT, He X. Frizzled and LRP5\/6 receptors for wnt\/\u03b2-catenin signaling. Cold Spring Harb Perspect Biol. 2012;4(12):a007880.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"843_CR15","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.virol.2014.09.007","volume":"468\u2013470","author":"S Sominsky","year":"2014","unstructured":"Sominsky S, Kuslansky Y, Shapiro B, Jackman A, Haupt Y, Rosin-Arbesfeld R, Sherman L. HPV16 e6 and e6AP differentially cooperate to stimulate or augment wnt signaling. Virology. 2014;468\u2013470:510\u201323.","journal-title":"Virology"},{"issue":"8","key":"843_CR16","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.3390\/v7082842","volume":"7","author":"JOM Bello","year":"2015","unstructured":"Bello JOM, Nieva LO, Paredes AC, Gonzalez AMF, Zavaleta LR, Lizano M. Regulation of the wnt\/\u03b2-catenin signaling pathway by human papillomavirus e6 and e7 oncoproteins. Viruses. 2015;7(8):4734\u201355.","journal-title":"Viruses"},{"issue":"Pt 3","key":"843_CR17","doi-asserted-by":"publisher","first-page":"142764","DOI":"10.1016\/j.ijbiomac.2025.142764","volume":"309","author":"L Lin","year":"2025","unstructured":"Lin L, Hasan MKE, Gu X, Khan SU, Hossain A, Faruqe MO, Shahriar S, Joy MNH, Sourov MMH, Khan MI, et al. Human tripartite motif-containing protein 71 NCL-1\/HT2a\/LIN-41 domain crystal structure and its potential natural inhibitors. Int J Biol Macromol. 2025;309(Pt 3):142764.","journal-title":"Int J Biol Macromol"},{"key":"843_CR18","first-page":"805","volume-title":"The stem cell-specific protein TRIM71 inhibits maturation and activity of the prodifferentiation miRNA let-7 via two independent molecular mechanisms","author":"LA Torres-Fern\u00e1ndez","year":"2021","unstructured":"Torres-Fern\u00e1ndez LA, Mitschka S, Ulas T, Weise S, Dahm K, Becker M, H\u00e4ndler K, Beyer M, Windhausen J, Schultze JL, et al. The stem cell-specific protein TRIM71 inhibits maturation and activity of the prodifferentiation miRNA let-7 via two independent molecular mechanisms. Volume 27. New York, N.Y.): RNA; 2021. pp. 805\u201328. 7."},{"issue":"48","key":"843_CR19","doi-asserted-by":"publisher","first-page":"79854","DOI":"10.18632\/oncotarget.13036","volume":"7","author":"J Yin","year":"2016","unstructured":"Yin J, Kim T, Park N, Shin D, Choi HI, Cho S, Park JB, Kim JH. TRIM71 suppresses tumorigenesis via modulation of lin28b-let-7-HMGA2 signaling. Oncotarget. 2016;7(48):79854\u201368.","journal-title":"Oncotarget"},{"issue":"7","key":"843_CR20","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1038\/bjc.2014.92","volume":"110","author":"W Wang","year":"2014","unstructured":"Wang W, Jia H, Huang J, Liang Y, Tan H, Geng H, Guo L, Yao S. Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics. Br J Cancer. 2014;110(7):1748\u201358.","journal-title":"Br J Cancer"},{"issue":"1","key":"843_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13046-016-0445-5","volume":"35","author":"T Liu","year":"2016","unstructured":"Liu T, Chen J, Shang C, Shen H, Huang J, Liang Y, Wang W, Zhao Y, Liu D, Shu M, et al. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-jun\/slug signaling-mediated epithelial-mesenchymal transition in cervical cancer. J Exp Clin Cancer Res. 2016;35(1):170.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"843_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.molcel.2017.03.014","volume":"66","author":"T Treiber","year":"2017","unstructured":"Treiber T, Treiber N, Plessmann U, Harlander S, Dai\u00df J, Eichner N, Lehmann G, Schall K, Urlaub H, Meister G. A compendium of RNA-binding proteins that regulate MicroRNA biogenesis. Mol Cell. 2017;66(2):270\u201384.","journal-title":"Mol Cell"},{"issue":"8","key":"843_CR23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41587-019-0206-z","volume":"37","author":"AT Satpathy","year":"2019","unstructured":"Satpathy AT, Granja JM, Yost KE, Qi Y, Meschi F, McDermott GP, Olsen BN, Mumbach MR, Pierce SE, Corces MR, et al. Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral t cell exhaustion. Nat Biotechnol. 2019;37(8):925\u201336.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"843_CR24","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-cas9 system. Nat Protoc. 2013;8(11):2281\u2013308.","journal-title":"Nat Protoc"},{"issue":"7","key":"843_CR25","first-page":"3801","volume":"35","author":"C Umbreit","year":"2015","unstructured":"Umbreit C, Erben P, Faber A, Hofheinz R, Aderhold C, Weiss C, Hoermann K, Wenzel A, Schultz JD. MMP9, cyclin d1 and \u03b2-catenin are useful markers of p16-positive squamous cell carcinoma in therapeutic EGFR inhibition in vitro. Anticancer Res. 2015;35(7):3801\u201310.","journal-title":"Anticancer Res"},{"issue":"1","key":"843_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.scib.2023.11.041","volume":"69","author":"F Shi","year":"2024","unstructured":"Shi F, Zhang K, Cheng Q, Che S, Zhi S, Yu Z, Liu F, Duan F, Wang Y, Yang N. Molecular mechanism governing RNA-binding property of mammalian TRIM71 protein. Sci Bull (Beijing). 2024;69(1):72\u201381.","journal-title":"Sci Bull (Beijing)"},{"issue":"10","key":"843_CR27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41419-019-1977-3","volume":"10","author":"Y Chen","year":"2019","unstructured":"Chen Y, Hao Q, Wang J, Li J, Huang C, Zhang Y, Wu X, Lu H, Zhou X. Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53. Cell Death Dis. 2019;10(10):737.","journal-title":"Cell Death Dis"},{"issue":"13","key":"843_CR28","doi-asserted-by":"publisher","first-page":"10880","DOI":"10.18632\/oncotarget.19075","volume":"9","author":"H Ren","year":"2017","unstructured":"Ren H, Xu Y, Wang Q, Jiang J, Wudumuli, Hui L, Zhang Q, Zhang X, Wang E, Sun L, et al. E3 ubiquitin ligase tripartite motif-containing 71 promotes the proliferation of non-small cell lung cancer through the inhibitor of kappab-\u03b1\/nuclear factor kappab pathway. Oncotarget. 2017;9(13):10880\u201390.","journal-title":"Oncotarget"},{"issue":"6","key":"843_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4143\/crt.2005.37.6.319","volume":"37","author":"E Yim","year":"2005","unstructured":"Yim E, Park J. The role of HPV e6 and e7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer Res Treat. 2005;37(6):319\u201324.","journal-title":"Cancer Res Treat"},{"issue":"6","key":"843_CR30","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3390\/ijms19061706","volume":"19","author":"NSL Yeo-Teh","year":"2018","unstructured":"Yeo-Teh NSL, Ito Y, Jha S. High-risk human papillomaviral oncogenes e6 and e7 target key cellular pathways to achieve oncogenesis. Int J Mol Sci. 2018;19(6):1706.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"843_CR31","first-page":"200","volume":"17","author":"E Ayala-Calvillo","year":"2018","unstructured":"Ayala-Calvillo E, Mojica-V\u00e1zquez LH, Garc\u00eda-Carranc\u00e1 A, Gonz\u00e1lez-Maya L. Wnt\/\u03b2\u2013catenin pathway activation and silencing of the APC gene in HPV\u2013positive human cervical cancer\u2013derived cells. Mol Med Rep. 2018;17(1):200\u201308.","journal-title":"Mol Med Rep"},{"issue":"7","key":"843_CR32","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.7150\/jca.22005","volume":"9","author":"M Yang","year":"2018","unstructured":"Yang M, Wang M, Li X, Xie Y, Xia X, Tian J, Zhang K, Tang A. Wnt signaling in cervical cancer? J Cancer. 2018;9(7):1277\u201386.","journal-title":"J Cancer"},{"issue":"13","key":"843_CR33","first-page":"5611","volume":"23","author":"C Liu","year":"2019","unstructured":"Liu C, Zhang H, Liu C, Wang C. Upregulation of lncRNA CALML3-as1 promotes cell proliferation and metastasis in cervical cancer via activation of the wnt\/\u03b2-catenin pathway. Eur Rev Med Pharmacol Sci. 2019;23(13):5611\u201320.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"843_CR34","doi-asserted-by":"publisher","first-page":"729228","DOI":"10.3389\/fonc.2021.729228","volume":"11","author":"S Trujano-Camacho","year":"2021","unstructured":"Trujano-Camacho S, Cant\u00fa-de Le\u00f3n D, Delgado-Waldo I, Coronel-Hern\u00e1ndez J, Millan-Catalan O, Hern\u00e1ndez-Sotelo D, L\u00f3pez-Camarillo C, P\u00e9rez-Plasencia C, Campos-Parra AD. Inhibition of wnt-\u03b2-catenin signaling by ICRT14 drug depends of post-transcriptional regulation by HOTAIR in human cervical cancer HeLa cells. Front Oncol. 2021;11:729228.","journal-title":"Front Oncol"},{"key":"843_CR35","doi-asserted-by":"publisher","first-page":"1354543","DOI":"10.3389\/fonc.2024.1354543","volume":"14","author":"K Li","year":"2024","unstructured":"Li K, Zhou Y, Zang M, Jin X, Li X. Therapeutic prospects of nectin-4 in cancer: applications and value. Front Oncol. 2024;14:1354543.","journal-title":"Front Oncol"},{"key":"843_CR36","doi-asserted-by":"publisher","first-page":"174516","DOI":"10.1016\/j.ejphar.2021.174516","volume":"911","author":"S Chatterjee","year":"2021","unstructured":"Chatterjee S, Sinha S, Kundu CN. Nectin cell adhesion molecule-4 (NECTIN-4): a potential target for cancer therapy. Eur J Pharmacol. 2021;911:174516.","journal-title":"Eur J Pharmacol"},{"key":"843_CR37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.biocel.2018.07.011","volume":"102","author":"S Siddharth","year":"2018","unstructured":"Siddharth S, Nayak A, Das S, Nayak D, Panda J, Wyatt MD, Kundu CN. The soluble nectin-4 ecto-domain promotes breast cancer induced angiogenesis via endothelial integrin-\u03b24. Int J Biochem Cell Biol. 2018;102:151\u201360.","journal-title":"Int J Biochem Cell Biol"},{"key":"843_CR38","doi-asserted-by":"publisher","first-page":"217681","DOI":"10.1016\/j.canlet.2025.217681","volume":"622","author":"M Nikanjam","year":"2025","unstructured":"Nikanjam M, P\u00e9rez-Granado J, Gramling M, Larvol B, Kurzrock R. Nectin-4 expression patterns and therapeutics in oncology. Cancer Lett. 2025;622:217681.","journal-title":"Cancer Lett"},{"issue":"16","key":"843_CR39","doi-asserted-by":"publisher","first-page":"6694","DOI":"10.1158\/0008-5472.CAN-09-0016","volume":"69","author":"A Takano","year":"2009","unstructured":"Takano A, Ishikawa N, Nishino R, Masuda K, Yasui W, Inai K, Nishimura H, Ito H, Nakayama H, Miyagi Y, et al. Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer. Cancer Res. 2009;69(16):6694\u2013703.","journal-title":"Cancer Res"},{"issue":"1","key":"843_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.canlet.2016.02.049","volume":"375","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Liu S, Wang L, Wu Y, Hao J, Wang Z, Lu W, Wang X, Zhang F, Cao Y, et al. A novel PI3k\/AKT signaling axis mediates nectin-4-induced gallbladder cancer cell proliferation, metastasis and tumor growth. Cancer Lett. 2016;375(1):179\u201389.","journal-title":"Cancer Lett"},{"key":"843_CR41","doi-asserted-by":"publisher","first-page":"699895","DOI":"10.3389\/fimmu.2021.699895","volume":"12","author":"Z Ge","year":"2021","unstructured":"Ge Z, Peppelenbosch MP, Sprengers D, Kwekkeboom J. TIGIT, the next step towards successful combination immune checkpoint therapy in cancer. Front Immunol. 2021;12:699895.","journal-title":"Front Immunol"},{"issue":"17","key":"843_CR42","doi-asserted-by":"publisher","first-page":"6895","DOI":"10.1074\/jbc.M116.769091","volume":"292","author":"M Maruoka","year":"2017","unstructured":"Maruoka M, Kedashiro S, Ueda Y, Mizutani K, Takai Y. Nectin-4 co-stimulates the prolactin receptor by interacting with SOCS1 and inhibiting its activity on the JAK2-STAT5a signaling pathway. J Biol Chem. 2017;292(17):6895\u2013909.","journal-title":"J Biol Chem"},{"key":"843_CR43","doi-asserted-by":"publisher","first-page":"103524","DOI":"10.1016\/j.esmoop.2024.103524","volume":"9","author":"MK Halle","year":"2024","unstructured":"Halle MK, Ulvang M, Berg HF, Woie K, Haldorsen I, Bertelsen B, Krakstad C. 24MO TROP-2, TF and NECTIN4 as targets for ADC treatment in cervical cancer. ESMO Open. 2024;9:103524.","journal-title":"ESMO Open"},{"issue":"8","key":"843_CR44","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1158\/1078-0432.CCR-22-3882","volume":"29","author":"DH Aggen","year":"2023","unstructured":"Aggen DH, Chu CE, Rosenberg JE. Scratching the surface: NECTIN-4 as a surrogate for enfortumab vedotin resistance. Clin Cancer Research: Official J Am Association Cancer Res. 2023;29(8):1377\u201380.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"key":"843_CR45","doi-asserted-by":"crossref","unstructured":"Jiang S, Guo H, Qu H, Bai Y, Shi B, Zhang P, Yao X, Yang TJ, Huang H, Cao M, et al. 9MW2821, a novel nectin-4 antibody-drug conjugate (ADC), combined with toripalimab in treatment-na\u00efve patients with locally advanced or metastatic urothelial carcinoma (la\/mUC): results from a phase 1b\/2 study. J Clin Oncol. 2025;43 Suppl 16:4519.","DOI":"10.1200\/JCO.2025.43.16_suppl.4519"},{"issue":"22","key":"843_CR46","first-page":"11861","volume":"47","author":"LA Torres-Fern\u00e1ndez","year":"2019","unstructured":"Torres-Fern\u00e1ndez LA, Jux B, Bille M, Port Y, Schneider K, Geyer M, Mayer G, Kolanus W. The mRNA repressor TRIM71 cooperates with nonsense-mediated decay factors to destabilize the mRNA of CDKN1a\/p21. Nucleic Acids Res. 2019;47(22):11861\u201379.","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"843_CR47","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1080\/15384101.2020.1804232","volume":"19","author":"DJ Foster","year":"2020","unstructured":"Foster DJ, Chang H, Haswell JR, Gregory RI, Slack FJ. TRIM71 binds to IMP1 and is capable of positive and negative regulation of target RNAs. Cell Cycle (Georgetown Tex). 2020;19(18):2314\u201326.","journal-title":"Cell Cycle (Georgetown Tex)"},{"key":"843_CR48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.biocel.2017.06.007","volume":"89","author":"S Siddharth","year":"2017","unstructured":"Siddharth S, Goutam K, Das S, Nayak A, Nayak D, Sethy C, Wyatt MD, Kundu CN. Nectin-4 is a breast cancer stem cell marker that induces WNT\/\u03b2-catenin signaling via pi3k\/akt axis. Int J Biochem Cell Biol. 2017;89:85\u201394.","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00843-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00843-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00843-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:17:24Z","timestamp":1786501044000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00843-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["843"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00843-y","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All human materials were obtained with informed consent and approved by the Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University. All animal-related experiments were conducted in accordance with ARRIVE guidelines and were approved by the Institutional Animal Care and Use Committee of Sun Yat-Sen University (SYSU-IACUC-2021-000273) and Ruiye model animal (Guangzhou) Biotechnology Co., Ltd Experimental Anima Ethics Committee Inspection (RYEth20210819-1).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"141"}}